Literature DB >> 11340757

[Insomnia. Prevalence and treatment of patients in general practice].

F C Blais1, C M Morin, A Boisclair, V Grenier, B Guay.   

Abstract

OBJECTIVE: To evaluate the prevalence of insomnia and the treatments used by patients attending general practice clinics.
DESIGN: Survey of outpatients.
SETTING: Quebec city, Que. metropolitan area. PARTICIPANTS: Two hundred eighteen patients recruited in waiting rooms of general practice clinics. MAIN OUTCOME MEASURES: Participants completed a survey on sleep and use of substances for insomnia, a questionnaire documenting their medical history and use of health care services, and three indices measuring presence of worry and symptoms of anxiety and depression. RESULT: Close to 38% of respondents suffered from insomnia: 26.2% had chronic insomnia and 11.4% had short-term insomnia. Prevalence was higher among women and people 35 to 54 years old. Among respondents who used substances to help them sleep, those 55 years and older consumed more prescription and medications (benzodiazepines); those 35 to 54 years old used mainly natural products; and those 16 to 34 years old consumed mainly over-the-counter medications. Respondents suffering from insomnia made heavier use of health care services and reported more worry and symptoms of anxiety and depression than those who slept well.
CONCLUSION: Patients attending general practice clinics have a high prevalence of insomnia. Physicians must be on the lookout for these sleep disturbances so they can offer appropriate treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11340757      PMCID: PMC2018415     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  20 in total

1.  Development and validation of the Penn State Worry Questionnaire.

Authors:  T J Meyer; M L Miller; R L Metzger; T D Borkovec
Journal:  Behav Res Ther       Date:  1990

2.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

3.  Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home.

Authors:  K Morgan; H Dallosso; S Ebrahim; T Arie; P H Fentem
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

4.  The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia.

Authors:  M Vollrath; W Wicki; J Angst
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Prevalence and treatment of insomnia in general practice. A longitudinal study.

Authors:  F Hohagen; K Rink; C Käppler; E Schramm; D Riemann; S Weyerer; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  [The Beck Anxiety Inventory. Psychometric properties of a French translation].

Authors:  M H Freeston; R Ladouceur; N Thibodeau; F Gagnon; J Rhéaume
Journal:  Encephale       Date:  1994 Jan-Feb       Impact factor: 1.291

7.  Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study.

Authors:  S Weyerer; H Dilling
Journal:  Sleep       Date:  1991-10       Impact factor: 5.849

8.  Insomnia and use of hypnotics: study of a French population.

Authors:  M A Quera-Salva; A Orluc; F Goldenberg; C Guilleminault
Journal:  Sleep       Date:  1991-10       Impact factor: 5.849

9.  Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men.

Authors:  T Gislason; M Almqvist
Journal:  Acta Med Scand       Date:  1987

10.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

Authors:  D E Ford; D B Kamerow
Journal:  JAMA       Date:  1989-09-15       Impact factor: 56.272

View more
  9 in total

1.  Study of the knowledge, beliefs, and practice of sleep among medical undergraduates of Tamilnadu, India.

Authors:  G Sivagnanam; P Thirumalaikolundusubramanian; P Sugirda; J Rajeswari; K Namasivayam; B Gitanjali
Journal:  MedGenMed       Date:  2004-10-12

Review 2.  Disorders of sleep: an overview.

Authors:  Leon Ting; Atul Malhotra
Journal:  Prim Care       Date:  2005-06       Impact factor: 2.907

3.  Generalized anxiety disorder and health care use.

Authors:  Lynda Bélanger; Robert Ladouceur; Charles M Morin
Journal:  Can Fam Physician       Date:  2005-10       Impact factor: 3.275

4.  Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior.

Authors:  Edouard-Jules Laforgue; Marion Istvan; Benoit Schreck; Marie Mainguy; Pascale Jolliet; Marie Grall-Bronnec; Caroline Victorri-Vigneau
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

5.  Insomnia and Relationship with Anxiety in University Students: A Cross-Sectional Designed Study.

Authors:  Nour Choueiry; Tracy Salamoun; Hicham Jabbour; Nada El Osta; Aline Hajj; Lydia Rabbaa Khabbaz
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

6.  Behavioral treatment of insomnia: a proposal for a stepped-care approach to promote public health.

Authors:  Laurin J Mack; Bruce D Rybarczyk
Journal:  Nat Sci Sleep       Date:  2011-07-26

7.  Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey.

Authors:  Margarita Blanco; Norberto Kriguer; Santiago Pérez Lloret; Daniel P Cardinali
Journal:  BMC Fam Pract       Date:  2003-11-20       Impact factor: 2.497

8.  Identifying Cases of Sleep Disorders through International Classification of Diseases (ICD) Codes in Administrative Data.

Authors:  Rachel J Jolley; Zhiying Liang; Mingkai Peng; Sachin R Pendharkar; Willis Tsai; Guanmin Chen; Cathy A Eastwood; Hude Quan; Paul E Ronksley
Journal:  Int J Popul Data Sci       Date:  2018-07-10

9.  Do older people know why they take benzodiazepines? A national French cross-sectional survey of long-term consumers.

Authors:  Edouard-Jules Laforgue; Alexandra Jobert; Morgane Rousselet; Marie Grall-Bronnec; Pascale Jolliet; Fanny Feuillet; Caroline Victorri-Vigneau
Journal:  Int J Geriatr Psychiatry       Date:  2020-04-21       Impact factor: 3.485

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.